In one of the largest healthcare investments in the Baltics, Mehiläinen acquires inMedica

Mehiläinen, Finland’s largest provider of social and healthcare services, has acquired the Lithuanian private medical services network, InMedica Group. The sale was agreed upon by the private equity fund INVL Baltic Sea Growth Fund, the healthcare services and pharmaceutical manufacturing group AB City, and the private company Litgaja.

The transaction is subject to approval by the competition authorities. Mehiläinen operates as a private provider of social and healthcare services in Finland, Sweden, Germany, and Estonia, with over 840 locations and 2.1 million customers. The company is committed to investing in digitalisation, as well as enhancing the efficiency and quality of healthcare across all its business areas.

Kęstutis Broniukaitis, CEO of InMedica Group, stated that the partnership will offer opportunities for professional collaboration, skill development, and the introduction of advanced technologies to benefit Lithuanian patients.

InMedica Group’s service philosophy aligns closely with Mehiläinen’s principles, making this partnership advantageous for patients, medical professionals, and employees alike. The transaction will not result in immediate changes, and day-to-day operations in Lithuania will continue as usual.

Andreas Taal, Mehiläinen’s Business Line Director for the Baltic region, highlighted that the rapid growth of the healthcare market in Lithuania, combined with InMedica Group’s market leadership, high-quality services, and excellent reputation, will enable the company to further expand and enhance the quality of its offerings.

Mehiläinen is advised on legal matters by the COBALT team, led by Managing Partner Dr Irmantas Norkus, Partner Dr Juozas Rimas, Specialist Counsel Sandra Juozaitienė, and Senior Associate Augustinas Petkevičius.